BioCentury
ARTICLE | Financial News

Ahead of new trials, Kadmon raises $100M

June 15, 2018 7:58 PM UTC

Kadmon Holdings Inc. (NYSE:KDMN) added $0.35 (10%) to $3.68 on June 12 after it raised $100 million in two offerings through the sale of 30.3 million shares at $3.30. The company sold the shares in a follow-on underwritten by Jefferies and H.C. Wainwright, and in a registered direct offering to institutional investors.

The price is a 1% discount to Kadmon's close of $3.35 on June 11, before it proposed the offering after market hours...